Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 280

Results For "ENT"

10709 News Found

Haleon invests Rs. 2000 crore to set up its first manufacturing facility in India
News | June 08, 2026

Haleon invests Rs. 2000 crore to set up its first manufacturing facility in India

The greenfield facility in Madhya Pradesh expected to create up to 500 direct jobs, in addition to generating indirect employment opportunities


Roche signs up to $2.3 billion deal with Nurix for BTK degrader Bexobrutideg
News | June 08, 2026

Roche signs up to $2.3 billion deal with Nurix for BTK degrader Bexobrutideg

The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases


Hinduja Hospital and Dr. Homi Bhabha State University to conduct PG allied health courses
Hospitals | June 08, 2026

Hinduja Hospital and Dr. Homi Bhabha State University to conduct PG allied health courses

The program expected to commence in August 2026 will be offered across multiple specialised areas with an intake of 20-30 students per course


Lupin Manufacturing Solutions appoints Eduardo Jule as Chief Commercial Officer
News | June 08, 2026

Lupin Manufacturing Solutions appoints Eduardo Jule as Chief Commercial Officer

Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy


Apollo Hospitals holds organ donation awareness
Hospitals | June 08, 2026

Apollo Hospitals holds organ donation awareness

Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation


Awshad launches Calmagummies Gold to tap cannabis-based wellness market
Healthcare | June 08, 2026

Awshad launches Calmagummies Gold to tap cannabis-based wellness market

Premium CBD+THC-infused gummies target stress relief, relaxation, and sleep recovery


Novo Nordisk's Zenagamtide shows strong HbA1c and weight loss benefits in phase II trial
R&D | June 08, 2026

Novo Nordisk's Zenagamtide shows strong HbA1c and weight loss benefits in phase II trial

Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions


Alembic Pharma receives USFDA approval for Haloperidol tablets
News | June 06, 2026

Alembic Pharma receives USFDA approval for Haloperidol tablets

The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical


Dr. L H Hiranandani Hospital expands cancer care with advanced radiation therapy unit
Hospitals | June 06, 2026

Dr. L H Hiranandani Hospital expands cancer care with advanced radiation therapy unit

The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services


Lupin secures U.S. FDA approval for interchangeable biosimilar Ranibizumab
Drug Approval | June 06, 2026

Lupin secures U.S. FDA approval for interchangeable biosimilar Ranibizumab

Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations